Top Page
Redox Limited
(Sydney:RDX)
Redox Limited (RDX) vs. iShares MSCI Australia ETF (EWA)
Redox Limited Business Overview & Revenue Model
Redox Limited Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 937.82M | 1.24B | 1.14B | 1.26B | 1.08B | 796.34M |
| Gross Profit | 202.59M | 268.63M | 265.93M | 262.03M | 243.79M | 164.92M |
| EBITDA | 84.95M | 122.94M | 139.68M | 137.07M | 138.31M | 81.97M |
| Net Income | 58.65M | 77.10M | 90.24M | 80.73M | 88.02M | 47.58M |
Balance Sheet | ||||||
| Total Assets | 732.21M | 732.21M | 702.38M | 579.86M | 639.56M | 428.72M |
| Cash, Cash Equivalents and Short-Term Investments | 123.83M | 123.83M | 179.29M | 35.03M | 40.60M | 23.24M |
| Total Debt | 49.99M | 49.99M | 47.04M | 217.86M | 261.82M | 154.28M |
| Total Liabilities | 187.94M | 187.94M | 171.11M | 344.90M | 405.74M | 246.60M |
| Stockholders Equity | 544.27M | 544.27M | 531.27M | 234.96M | 233.82M | 182.13M |
Cash Flow | ||||||
| Free Cash Flow | 25.86M | 42.72M | 112.06M | 131.63M | -50.56M | 29.88M |
| Operating Cash Flow | 29.89M | 47.83M | 115.89M | 134.74M | -48.98M | 32.24M |
| Investing Cash Flow | 11.42M | 11.42M | -125.25M | -2.81M | -1.22M | -2.09M |
| Financing Cash Flow | -73.30M | -73.30M | 30.88M | -137.05M | 67.75M | -25.48M |
Redox Limited Technical Analysis
Redox Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$1.44B | 18.66 | 14.34% | 4.65% | 9.36% | -14.60% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | AU$77.37M | 62.37 | 3.53% | ― | 24.88% | ― | |
47 Neutral | AU$154.44M | -17.88 | -55.86% | ― | ― | 64.63% | |
45 Neutral | AU$98.73M | -5.21 | -39.14% | ― | ― | 57.49% | |
45 Neutral | AU$852.95M | -26.22 | -13.97% | ― | 620.73% | -21.19% |
Redox Limited Corporate Events
Redox Limited has announced a change in the interest of its director, Richard Raymond Coneliano, with the acquisition of 161,108 Long Term Incentive (LTI) Performance Rights. This change, approved at the company’s Annual General Meeting, reflects a strategic move to align the director’s incentives with the company’s long-term goals, potentially impacting the company’s operational focus and stakeholder interests.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited has announced a change in the director’s interest, specifically for Renato Coneliano, who has been granted 158,819 Long Term Incentive (LTI) Performance Rights. This change was approved by the shareholders at the Annual General Meeting on 8 October 2025, and it reflects the company’s commitment to aligning director incentives with long-term performance goals, potentially impacting the company’s strategic direction and stakeholder value.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited has announced a change in the director’s interest notice, specifically regarding Raimond Heath Coneliano. The company has granted 421,883 Long Term Incentive Performance Rights to Mr. Coneliano under its Long Term Incentive Plan, which was approved at the Annual General Meeting on October 8, 2025. This move reflects Redox Limited’s commitment to aligning its leadership incentives with long-term company performance, potentially impacting its strategic direction and shareholder value.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
At its 2025 Annual General Meeting, Redox Limited reported strong financial performance despite global economic challenges, with a 9.4% increase in sales revenue and a 1% rise in gross profit. The company emphasized its commitment to Environmental, Social, and Governance (ESG) initiatives and shareholder returns, paying out 12.5 cents per share, surpassing its dividend policy. The board highlighted its focus on maintaining a straightforward executive remuneration strategy centered on total shareholder return, while expressing confidence in the company’s financial strength with $124 million in cash and $185 million in unused debt facilities.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited has announced its 2025 Annual General Meeting, scheduled for October 8, 2025, at Swissotel Sydney. The meeting will be conducted in a hybrid format, allowing shareholders to participate both in-person and online. Key agenda items include the consideration of the company’s financial and remuneration reports, the re-election of director Mary Verschuer, and the approval of performance rights for executive directors Raimond and Renato Coneliano. These decisions are pivotal for the company’s governance and executive compensation strategy.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited has released its Annual Report for 2025, detailing various aspects of its corporate performance and governance. The report includes insights into the company’s financial position, operational reviews, and ESG initiatives, providing stakeholders with a comprehensive overview of Redox Limited’s activities and strategic direction for the year.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited announced a change in the indirect interest of its director, Garry Ronald Wayling, in the company’s ordinary shares. On August 22, 2025, Wayling acquired 7,670 additional shares through an on-market trade, increasing his indirect holdings to 27,278 shares. This transaction highlights the director’s growing investment in the company, potentially signaling confidence in Redox Limited’s future performance.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited has released its corporate governance statement for the financial year ending June 30, 2025. The statement, approved by the board, outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations. Redox Limited has disclosed its board charter and other governance practices on its website, ensuring transparency and accountability in its management and oversight roles. This announcement highlights Redox Limited’s commitment to maintaining robust corporate governance practices, which is crucial for its stakeholders and aligns with industry standards.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited has announced a dividend distribution of AUD 0.065 per share for its ordinary fully paid securities. The dividend relates to the financial period ending on June 30, 2025, with an ex-date of August 26, 2025, and a payment date set for September 23, 2025. This announcement reflects the company’s financial performance over the past six months and may impact shareholder returns and market perception.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited has released its 2025 Corporate Governance Statement, outlining its commitment to maintaining strong governance practices. The statement highlights the company’s focus on diversity, equity, and inclusion, as well as promoting responsible and ethical behaviors. This announcement underscores Redox Limited’s dedication to robust corporate governance, potentially enhancing its reputation and trust among stakeholders.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited reported a robust financial performance for FY25, with a 9.4% increase in revenue to $1.244 billion, driven by strong volume growth despite a challenging macroeconomic environment. The company completed three acquisitions, enhancing its product portfolio and market reach, and maintained a strong cash position with zero net debt. Redox expanded its sales team and signed new channel partnerships, positioning itself for future growth in the chemicals industry. The company declared a final dividend of 6.5 cents per share, reflecting confidence in its financial strength and prospects. Looking ahead, Redox plans to focus on organic growth, strategic M&A, and expanding its presence in North America.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited reported a 9.4% increase in revenues from ordinary activities for the year ended 30 June 2025, reaching $1,243,797,000. However, the company’s profit after tax decreased by 14.6% to $77,101,000, compared to the previous year. Despite the decline in profit, Redox Limited declared a fully franked final dividend of 6.5 cents per share, resulting in a total of 12.5 cents per share for the year. The company also gained control over several entities, including Oleum Holdings Pty Ltd and Molekulis Pty Ltd, which may impact its future operations and market positioning.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited announced the release of 276,563,815 fully paid ordinary shares from escrow, effective on 21 August 2025, in accordance with ASX Listing Rule 3.10A. This release marks a significant step for the company, potentially impacting its market positioning and providing increased liquidity for stakeholders, as these shares were initially restricted when Redox was admitted to the ASX Official List.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited announced that it will release its FY25 Financial Results and Investor Presentation on 21 August 2025. Following the release, the company will host an investor conference call and webcast, including a Q&A session, to discuss the results. This announcement highlights Redox’s commitment to transparency and engagement with its investors, potentially impacting its market positioning and stakeholder relations positively.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.
Redox Limited announced that its 2025 Annual General Meeting (AGM) will be held on October 8, 2025, at Swissotel Sydney as a hybrid meeting, allowing both in-person and online participation. The deadline for director nominations is set for August 5, 2025. This meeting is crucial for stakeholders as it will outline the company’s strategic direction and governance, impacting its future operations and industry positioning.
The most recent analyst rating on (AU:RDX) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Redox Limited stock, see the AU:RDX Stock Forecast page.